Permanent silencing of NKG2A expression for cell-based therapeutics (Q39918666)

15 September 2017

Permanent silencing of NKG2A expression for cell-based therapeutics (English)

1 reference

15 September 2017

Constança Figueiredo

1

1 reference

PubMed ID

19002424

15 September 2017

Axel Seltsam

series ordinal

2

1 reference

PubMed ID

19002424

15 September 2017

Rainer Blasczyk

series ordinal

3

1 reference

15 September 2017

11 November 2008

1 reference

Journal of Molecular Medicine

15 September 2017

1 reference

15 September 2017

87

1 reference

15 September 2017

2

1 reference

15 September 2017

199-210

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-008-0417-0

15 September 2017

0 references

cites work

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

RNAi and gene therapy: a mutual attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-008-0417-0

Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy

21 January 2018

1 reference

12 December 2020

Activation of the interferon system by short-interfering RNAs

1 reference

12 December 2020

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

1 reference

12 December 2020

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

1 reference

12 December 2020

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

12 December 2020

Lentiviral vector-mediated RNAi and its use for cancer research

1 reference

12 December 2020

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

12 December 2020

Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clin

1 reference

12 December 2020

Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells

1 reference

12 December 2020

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

1 reference

12 December 2020

Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals

1 reference

12 December 2020

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

1 reference

12 December 2020

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

1 reference

12 December 2020

Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC.

1 reference

12 December 2020

Regulation of the natural killer cell receptor repertoire

1 reference

12 December 2020

Toll-like receptors in innate immunity

1 reference

12 December 2020

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.

1 reference

12 December 2020

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro

1 reference

12 December 2020

Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.

1 reference

12 December 2020

Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.

1 reference

12 December 2020

Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma

1 reference

12 December 2020

Progress and prospects: RNA-based therapies for treatment of HIV infection.

1 reference

12 December 2020

Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers

1 reference

12 December 2020

Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.

1 reference

12 December 2020

Overcoming the innate immune response to small interfering RNA.

1 reference

12 December 2020

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

1 reference

12 December 2020

Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status

1 reference

12 December 2020

Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases

1 reference

12 December 2020

Activation of the mammalian immune system by siRNAs.

1 reference

12 December 2020

Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells

1 reference

12 December 2020

IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion

1 reference

12 December 2020

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

1 reference

12 December 2020

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

1 reference

12 December 2020

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells

1 reference

12 December 2020

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

1 reference

12 December 2020

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion

1 reference

12 December 2020

Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.

1 reference

12 December 2020

Toll-like receptor control of the adaptive immune responses

1 reference

12 December 2020

Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant

1 reference

12 December 2020

Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells

1 reference

12 December 2020

Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis

1 reference

12 December 2020

Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors

1 reference

12 December 2020

Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects

1 reference

12 December 2020

Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection

1 reference

12 December 2020

High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity

1 reference

12 December 2020

Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors

1 reference

12 December 2020

10.1007/S00109-008-0417-0

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

19002424